1,056 followers
RT @DryAMD: RT @YoungRetina: Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-…
13 followers
RT @YoungRetina: Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-center experience https://t.co/Jj323pPDxu #retina #ophthalmology #macularteleangiectasia https://t.co/eGrkf8mK27
1,056 followers
RT @YoungRetina: Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-center exper…
2,080 followers
Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-center experience https://t.co/SrfX9NqxMo #retina #ophthalmology #macularteleangiectasia https://t.co/W9jHI1kJTb
159 followers
Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia https://t.co/R01tI4Csdu https://t.co/lMIEjbzWti
13 followers
RT @EyeVidence: In a small test group of 82 eyes with non-proliferative Idiopathic Macular Telangiectasia Type 2, the off-label use of #AREDS2 supplements showed positive effects and may prevent anatomical and visual deterioration. https://t.co/jDRq4lZnFz
198 followers
In a small test group of 82 eyes with non-proliferative Idiopathic Macular Telangiectasia Type 2, the off-label use of #AREDS2 supplements showed positive effects and may prevent anatomical and visual deterioration. https://t.co/ZhOZuJScRP
1,474 followers
Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia https://t.co/8x7MG7qnEj
2,200 followers
Ophthopedia Update: Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia https://t.co/F2C3bEhKMw #Ophthomology #Eye #Ophthotwitter